Description
Legalon sIL Powder for Solution for Infusions 350 mg. №4
Ingredients:
Each vial contains 350 mg of Legalon sIL powder for solution for infusions. The active ingredient is silybin, a flavonolignan complex extracted from milk thistle seeds.
Mechanism of Action:
Silybin, the primary component of Legalon sIL, acts as a hepatoprotective agent by exerting antioxidant, anti-inflammatory, and antifibrotic effects. It helps in safeguarding liver cells from damage and facilitating liver regeneration.
Pharmacological Properties:
Legalon sIL exhibits hepatoprotective properties attributed to silybin’s ability to mitigate oxidative stress, reduce inflammation, and inhibit fibrosis within the liver tissue.
Indications for Use:
Legalon sIL is indicated for the treatment of liver diseases such as acute and chronic hepatitis, cirrhosis, and toxic liver damage. It aids in preserving liver cell integrity and enhancing overall liver function.
Contraindications:
Do not use Legalon sIL if you are allergic to silybin or any other components of the product. Prior consultation with a healthcare provider is essential, particularly for individuals with known allergies or underlying medical conditions.
Side Effects:
Common side effects of Legalon sIL may include gastrointestinal disturbances. Patients should promptly seek medical advice in case of any adverse reactions or unexpected symptoms.
Usage Instructions:
Legalon sIL should be administered intravenously under the supervision of a healthcare professional. The dosage and infusion duration must adhere to the prescribed regimen provided by the healthcare provider.
Benefits Compared to Analogues:
Legalon sIL stands out from other products due to its potent hepatoprotective effects attributed to silybin. The unique formulation of Legalon sIL offers comprehensive liver support and has demonstrated efficacy in various liver conditions.
Suitable Patient Groups:
Legalon sIL is suitable for a wide range of patient groups, including adults, children, and the elderly, under appropriate medical supervision. Dosage adjustments may be necessary based on individual patient characteristics.
Storage and Shelf Life:
- Storage: Legalon sIL should be stored in accordance with the recommended temperature guidelines and shielded from direct light exposure.
- Shelf Life: The product’s shelf life should be checked and adhered to as per the manufacturer’s instructions to ensure efficacy and safety.
Packaging Description:
Legalon sIL is typically available in vials containing 350 mg of powder for solution for infusions. The packaging is designed to maintain product integrity and sterility until the point of administration.
Clinical Evidence and Proven Effectiveness:
Silybin, the active ingredient in Legalon sIL, has been the subject of extensive research validating its hepatoprotective properties. Clinical studies have demonstrated the efficacy of Legalon sIL in improving liver function markers and ameliorating liver inflammation across various liver diseases.
